← All organizations

Tarsa Therapeutics, Inc.

For profitWebsite ↗

Also known as: Chief Medical Officer - Tarsa Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 1, 2011

Acquired by R-Pharm on Mar 1, 2019

Timeline

2000s

Jun 1, 2009
Tarsa Therapeutics, Inc.— Founded

2010s

Mar 1, 2019
R-Pharm— Acquired By

Drugs by trial phase (1 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

calcitonin salmon

Indications

Studied for

Recent trials (6)

NCT01292187Study directorPhase 2Jan 1, 2011
NCT01292187Lead sponsorPhase 2Jan 1, 2011
NCT00959764Lead sponsorPhase 3Jun 1, 2009
NCT00959764Study directorPhase 3Jun 1, 2009
NCT00803686Lead sponsorPhase 2Dec 1, 2008
NCT00620854Lead sponsorPhase 2Feb 1, 2008

Details

Founded: Philadelphia, PA, US Jun 1, 2009
Last known activity: Jan 1, 2011